BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 20357361)

  • 1. Simultaneous detection of circulating autoreactive CD8+ T-cells specific for different islet cell-associated epitopes using combinatorial MHC multimers.
    Velthuis JH; Unger WW; Abreu JR; Duinkerken G; Franken K; Peakman M; Bakker AH; Reker-Hadrup S; Keymeulen B; Drijfhout JW; Schumacher TN; Roep BO
    Diabetes; 2010 Jul; 59(7):1721-30. PubMed ID: 20357361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of low-affinity preproinsulin epitopes and detection of autoreactive CD8 T-cells using combinatorial MHC multimers.
    Unger WW; Velthuis J; Abreu JR; Laban S; Quinten E; Kester MG; Reker-Hadrup S; Bakker AH; Duinkerken G; Mulder A; Franken KL; Hilbrands R; Keymeulen B; Peakman M; Ossendorp F; Drijfhout JW; Schumacher TN; Roep BO
    J Autoimmun; 2011 Nov; 37(3):151-9. PubMed ID: 21636247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recognition of HLA class I-restricted beta-cell epitopes in type 1 diabetes.
    Ouyang Q; Standifer NE; Qin H; Gottlieb P; Verchere CB; Nepom GT; Tan R; Panagiotopoulos C
    Diabetes; 2006 Nov; 55(11):3068-74. PubMed ID: 17065344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Islet-specific CTL cloned from a type 1 diabetes patient cause beta-cell destruction after engraftment into HLA-A2 transgenic NOD/scid/IL2RG null mice.
    Unger WW; Pearson T; Abreu JR; Laban S; van der Slik AR; der Kracht SM; Kester MG; Serreze DV; Shultz LD; Griffioen M; Drijfhout JW; Greiner DL; Roep BO
    PLoS One; 2012; 7(11):e49213. PubMed ID: 23155466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The frequency and immunodominance of islet-specific CD8+ T-cell responses change after type 1 diabetes diagnosis and treatment.
    Martinuzzi E; Novelli G; Scotto M; Blancou P; Bach JM; Chaillous L; Bruno G; Chatenoud L; van Endert P; Mallone R
    Diabetes; 2008 May; 57(5):1312-20. PubMed ID: 18305140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early autoimmune destruction of islet grafts is associated with a restricted repertoire of IGRP-specific CD8+ T cells in diabetic nonobese diabetic mice.
    Wong CP; Li L; Frelinger JA; Tisch R
    J Immunol; 2006 Feb; 176(3):1637-44. PubMed ID: 16424193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dendritic Cells Guide Islet Autoimmunity through a Restricted and Uniquely Processed Peptidome Presented by High-Risk HLA-DR.
    van Lummel M; van Veelen PA; de Ru AH; Janssen GM; Pool J; Laban S; Joosten AM; Nikolic T; Drijfhout JW; Mearin ML; Aanstoot HJ; Peakman M; Roep BO
    J Immunol; 2016 Apr; 196(8):3253-63. PubMed ID: 26944932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IGRP and insulin vaccination induce CD8+ T cell-mediated autoimmune diabetes in the RIP-CD80GP mouse.
    Fuchs YF; Adler K; Lindner A; Karasinsky A; Wilhelm C; Weigelt M; Balke H; Förtsch K; Mortler-Hildebrandt LF; Harlan DM; Pechhold K; Ziegler AG; Bonifacio E
    Clin Exp Immunol; 2014 May; 176(2):199-206. PubMed ID: 24387268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combinatorial detection of autoreactive CD8
    James EA; Abreu JRF; McGinty JW; Odegard JM; Fillié YE; Hocter CN; Culina S; Ladell K; Price DA; Alkanani A; Rihanek M; Fitzgerald-Miller L; Skowera A; Speake C; Gottlieb P; Davidson HW; Wong FS; Roep B; Mallone R;
    Diabetologia; 2018 Mar; 61(3):658-670. PubMed ID: 29196783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating β cell-specific CD8
    Yeo L; Pujol-Autonell I; Baptista R; Eichmann M; Kronenberg-Versteeg D; Heck S; Dolton G; Sewell AK; Härkönen T; Mikk ML; Toppari J; Veijola R; Knip M; Ilonen J; Peakman M
    Clin Exp Immunol; 2020 Mar; 199(3):263-277. PubMed ID: 31660582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD8 T cell autoreactivity to preproinsulin epitopes with very low human leucocyte antigen class I binding affinity.
    Abreu JR; Martina S; Verrijn Stuart AA; Fillié YE; Franken KL; Drijfhout JW; Roep BO
    Clin Exp Immunol; 2012 Oct; 170(1):57-65. PubMed ID: 22943201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoreactive CD8 T cells associated with beta cell destruction in type 1 diabetes.
    Pinkse GG; Tysma OH; Bergen CA; Kester MG; Ossendorp F; van Veelen PA; Keymeulen B; Pipeleers D; Drijfhout JW; Roep BO
    Proc Natl Acad Sci U S A; 2005 Dec; 102(51):18425-30. PubMed ID: 16339897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating preproinsulin signal peptide-specific CD8 T cells restricted by the susceptibility molecule HLA-A24 are expanded at onset of type 1 diabetes and kill β-cells.
    Kronenberg D; Knight RR; Estorninho M; Ellis RJ; Kester MG; de Ru A; Eichmann M; Huang GC; Powrie J; Dayan CM; Skowera A; van Veelen PA; Peakman M
    Diabetes; 2012 Jul; 61(7):1752-9. PubMed ID: 22522618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HLA class I epitope discovery in type 1 diabetes: independent and reproducible identification of proinsulin epitopes of CD8 T cells--report of the IDS T Cell Workshop Committee.
    Pinkse GG; Boitard C; Tree TI; Peakman M; Roep BO
    Ann N Y Acad Sci; 2006 Oct; 1079():19-23. PubMed ID: 17130527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of novel IGRP epitopes targeted in type 1 diabetes patients.
    Jarchum I; Nichol L; Trucco M; Santamaria P; DiLorenzo TP
    Clin Immunol; 2008 Jun; 127(3):359-65. PubMed ID: 18358785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Local autoantigen expression as essential gatekeeper of memory T-cell recruitment to islet grafts in diabetic hosts.
    Alkemade GM; Clemente-Casares X; Yu Z; Xu BY; Wang J; Tsai S; Wright JR; Roep BO; Santamaria P
    Diabetes; 2013 Mar; 62(3):905-11. PubMed ID: 23160528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different diabetogenic potential of autoaggressive CD8+ clones associated with IFN-gamma-inducible protein 10 (CXC chemokine ligand 10) production but not cytokine expression, cytolytic activity, or homing characteristics.
    Ejrnaes M; Videbaek N; Christen U; Cooke A; Michelsen BK; von Herrath M
    J Immunol; 2005 Mar; 174(5):2746-55. PubMed ID: 15728483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of Novel HLA-A*0201-restricted epitopes in recent-onset type 1 diabetic subjects and antibody-positive relatives.
    Standifer NE; Ouyang Q; Panagiotopoulos C; Verchere CB; Tan R; Greenbaum CJ; Pihoker C; Nepom GT
    Diabetes; 2006 Nov; 55(11):3061-7. PubMed ID: 17065343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Equivalent specificity of peripheral blood and islet-infiltrating CD8+ T lymphocytes in spontaneously diabetic HLA-A2 transgenic NOD mice.
    Enée E; Martinuzzi E; Blancou P; Bach JM; Mallone R; van Endert P
    J Immunol; 2008 Apr; 180(8):5430-8. PubMed ID: 18390725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoreactive effector/memory CD4+ and CD8+ T cells infiltrating grafted and endogenous islets in diabetic NOD mice exhibit similar T cell receptor usage.
    Diz R; Garland A; Vincent BG; Johnson MC; Spidale N; Wang B; Tisch R
    PLoS One; 2012; 7(12):e52054. PubMed ID: 23251685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.